Reducing bleeding with the contraceptive implant

Are you a woman using the contraceptive implant (Nexplanon or Implanon)?

Tamoxifen Study ImageeIRB study # 10228 (PI:  Katharine Simmons, MD)

The Women’s Health Research Unit is recruiting for a clinical research study evaluating if a drug can help reduce irregular bleeding in women who use the implant for contraception.

Trial Status: 

  • Open to Enrollment

To Qualify:

You should be between the ages of 15 and 45, be experiencing frequent or persistent bleeding while using the implant, and in good general health. You also need to have a cell phone that is capable of receiving text or email messages. Participation in the study will last 6 months and requires 5 visits to OHSU.

Qualified participants will receive at no cost:

  • Study related physical and gynecologic exams
  • Investigational study drug (tamoxifen) or placebo
  • Up to $330 in compensation for time and travel over the course of the study

Who do I contact for additional information?

To find out more information and to learn if you are qualified to participate, fill out the online form or call the Women’s Health Research Unit confidential recruitment line.

Complete the Online Form or call 503-494-3666